Actinogen Medical Limited (AU:ACW) has released an update.
Actinogen Medical Limited has announced plans to issue a substantial number of new securities, comprising 174,375,000 listed options expiring in September 2027 at $0.05 each, and 232,500,000 ordinary shares. The issuance is scheduled for 24th September 2024, signaling a significant move by the company to raise capital or engage in strategic financial restructuring.
For further insights into AU:ACW stock, check out TipRanks’ Stock Analysis page.
